UniProt ID | SPDLY_HUMAN | |
---|---|---|
UniProt AC | Q96EA4 | |
Protein Name | Protein Spindly {ECO:0000255|HAMAP-Rule:MF_03041} | |
Gene Name | SPDL1 {ECO:0000255|HAMAP-Rule:MF_03041} | |
Organism | Homo sapiens (Human). | |
Sequence Length | 605 | |
Subcellular Localization | Cytoplasm, cytoskeleton, microtubule organizing center, centrosome. Chromosome, centromere, kinetochore. Nucleus. Cytoplasm, cytoskeleton, spindle pole. Localizes to the nucleus in interphase and to the kinetochore in early prometaphase. Relocalizes | |
Protein Description | Required for the localization of dynein and dynactin to the mitotic kintochore. Dynein is believed to control the initial lateral interaction between the kinetochore and spindle microtubules and to facilitate the subsequent formation of end-on kinetochore-microtubule attachments mediated by the NDC80 complex. Also required for correct spindle orientation. Does not appear to be required for the removal of spindle assembly checkpoint (SAC) proteins from the kinetochore upon bipolar spindle attachment. [PubMed: 17576797] | |
Protein Sequence | MEADIITNLRCRLKEAEEERLKAAQYGLQLVESQNELQNQLDKCRNEMMTMTESYEQEKYTLQREVELKSRMLESLSCECEAIKQQQKMHLEKLEEQLSRSHGQEVNELKTKIEKLKVELDEARLSEKQLKHQVDHQKELLSCKSEELRVMSERVQESMSSEMLALQIELTEMESMKTTLKEEVNELQYRQEQLELLITNLMRQVDRLKEEKEEREKEAVSYYNALEKARVANQDLQVQLDQALQQALDPNSKGNSLFAEVEDRRAAMERQLISMKVKYQSLKKQNVFNREQMQRMKLQIATLLQMKGSQTEFEQQERLLAMLEQKNGEIKHLLGEIRNLEKFKNLYDSMESKPSVDSGTLEDNTYYTDLLQMKLDNLNKEIESTKGELSIQRMKALFESQRALDIERKLFANERCLQLSESENMKLRAKLDELKLKYEPEETVEVPVLKKRREVLPVDITTAKDACVNNSALGGEVYRLPPQKEETQSCPNSLEDNNLQLEKSVSIYTPVVSLSPHKNLPVDMQLKKEKKCVKLIGVPADAEALSERSGNTPNSPRLAAESKLQTEVKEGKETSSKLEKETCKKLHPILYVSSKSTPETQCPQQ | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
1 | Acetylation | -------MEADIITN -------CCCHHHHH | 9.63 | 22814378 | |
126 | Phosphorylation | ELDEARLSEKQLKHQ HHHHHHCCHHHHHHH | 36.88 | 27762562 | |
145 | Phosphorylation | KELLSCKSEELRVMS HHHHHCCHHHHHHHH | 40.40 | 27251275 | |
154 | Methylation | ELRVMSERVQESMSS HHHHHHHHHHHHCCH | 28.28 | - | |
178 | Phosphorylation | TEMESMKTTLKEEVN HHHHHHHHHHHHHHH | 28.81 | 22210691 | |
179 | Phosphorylation | EMESMKTTLKEEVNE HHHHHHHHHHHHHHH | 30.25 | 22210691 | |
221 | Phosphorylation | EREKEAVSYYNALEK HHHHHHHHHHHHHHH | 29.02 | 23828894 | |
228 | Ubiquitination | SYYNALEKARVANQD HHHHHHHHHHHHCCC | 42.20 | 29967540 | |
256 | Phosphorylation | DPNSKGNSLFAEVED CCCCCCCCCHHHHHH | 33.27 | 28555341 | |
260 | Ubiquitination | KGNSLFAEVEDRRAA CCCCCHHHHHHHHHH | 38.82 | 33845483 | |
279 | Phosphorylation | LISMKVKYQSLKKQN HHHHHHHHHHHHHCC | 13.30 | 24043423 | |
281 | Phosphorylation | SMKVKYQSLKKQNVF HHHHHHHHHHHCCCC | 38.78 | 24043423 | |
303 | Ubiquitination | MKLQIATLLQMKGSQ HHHHHHHHHHHCCCC | 2.01 | 32015554 | |
315 | Ubiquitination | GSQTEFEQQERLLAM CCCCHHHHHHHHHHH | 56.61 | 33845483 | |
331 | Ubiquitination | EQKNGEIKHLLGEIR HHHCHHHHHHHHHHH | 24.73 | 33845483 | |
347 | Phosphorylation | LEKFKNLYDSMESKP HHHHHHHHHHCCCCC | 18.50 | 25159151 | |
355 | Phosphorylation | DSMESKPSVDSGTLE HHCCCCCCCCCCCCC | 42.14 | 30576142 | |
360 | Phosphorylation | KPSVDSGTLEDNTYY CCCCCCCCCCCCCHH | 30.81 | 30576142 | |
365 | Phosphorylation | SGTLEDNTYYTDLLQ CCCCCCCCHHHHHHH | 30.17 | 30576142 | |
366 | Phosphorylation | GTLEDNTYYTDLLQM CCCCCCCHHHHHHHH | 15.60 | 27642862 | |
367 | Phosphorylation | TLEDNTYYTDLLQMK CCCCCCHHHHHHHHH | 7.55 | 27642862 | |
368 | Phosphorylation | LEDNTYYTDLLQMKL CCCCCHHHHHHHHHH | 15.12 | 29978859 | |
374 | Ubiquitination | YTDLLQMKLDNLNKE HHHHHHHHHHHHHHH | 39.46 | 32015554 | |
386 | Ubiquitination | NKEIESTKGELSIQR HHHHHHCCCHHHHHH | 60.72 | 33845483 | |
390 | Phosphorylation | ESTKGELSIQRMKAL HHCCCHHHHHHHHHH | 16.63 | 24719451 | |
405 (in isoform 2) | Phosphorylation | - | 39.45 | 21406692 | |
407 (in isoform 2) | Phosphorylation | - | 43.35 | 21406692 | |
409 | Ubiquitination | RALDIERKLFANERC HHHHHHHHHHHCHHH | 34.86 | 29967540 | |
410 (in isoform 2) | Phosphorylation | - | 6.50 | 21406692 | |
414 (in isoform 2) | Phosphorylation | - | 41.14 | 21406692 | |
416 (in isoform 2) | Phosphorylation | - | 2.01 | 21406692 | |
461 | Phosphorylation | EVLPVDITTAKDACV CCCCCCCCCCHHHHC | 19.08 | - | |
471 | Phosphorylation | KDACVNNSALGGEVY HHHHCCCCCCCCCEE | 21.48 | 21815630 | |
484 | Phosphorylation | VYRLPPQKEETQSCP EEECCCCCCCCCCCC | 64.39 | 33259812 | |
487 | Phosphorylation | LPPQKEETQSCPNSL CCCCCCCCCCCCCCC | 27.20 | 17525332 | |
489 | Phosphorylation | PQKEETQSCPNSLED CCCCCCCCCCCCCCC | 38.67 | 25627689 | |
492 | Ubiquitination | EETQSCPNSLEDNNL CCCCCCCCCCCCCCC | 64.65 | 32015554 | |
493 | Phosphorylation | ETQSCPNSLEDNNLQ CCCCCCCCCCCCCCC | 20.48 | 25159151 | |
504 | Phosphorylation | NNLQLEKSVSIYTPV CCCCEEEEEEEEECC | 16.24 | 28450419 | |
506 | Phosphorylation | LQLEKSVSIYTPVVS CCEEEEEEEEECCEE | 19.57 | 28450419 | |
508 | Phosphorylation | LEKSVSIYTPVVSLS EEEEEEEEECCEECC | 9.48 | 28450419 | |
509 | Phosphorylation | EKSVSIYTPVVSLSP EEEEEEEECCEECCC | 14.13 | 28450419 | |
513 | Phosphorylation | SIYTPVVSLSPHKNL EEEECCEECCCCCCC | 24.30 | 22617229 | |
515 | Phosphorylation | YTPVVSLSPHKNLPV EECCEECCCCCCCCC | 19.90 | 22617229 | |
534 | Acetylation | KKEKKCVKLIGVPAD CCCCCCEEECCCCCC | 43.80 | 25953088 | |
546 | Phosphorylation | PADAEALSERSGNTP CCCHHHHHHHCCCCC | 37.70 | 21815630 | |
549 | Phosphorylation | AEALSERSGNTPNSP HHHHHHHCCCCCCCH | 32.13 | 22199227 | |
552 | Phosphorylation | LSERSGNTPNSPRLA HHHHCCCCCCCHHHH | 27.63 | 23663014 | |
555 | Phosphorylation | RSGNTPNSPRLAAES HCCCCCCCHHHHHHH | 16.76 | 25159151 | |
562 | Phosphorylation | SPRLAAESKLQTEVK CHHHHHHHHHHHHHH | 33.66 | 26074081 | |
563 | Ubiquitination | PRLAAESKLQTEVKE HHHHHHHHHHHHHHC | 35.80 | 32015554 | |
566 | Phosphorylation | AAESKLQTEVKEGKE HHHHHHHHHHHCCCC | 53.86 | - | |
593 | Phosphorylation | LHPILYVSSKSTPET HCCEEEECCCCCCCC | 20.63 | 22210691 | |
594 | Phosphorylation | HPILYVSSKSTPETQ CCEEEECCCCCCCCC | 22.15 | 22210691 | |
600 | Phosphorylation | SSKSTPETQCPQQ-- CCCCCCCCCCCCC-- | 36.35 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of SPDLY_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference |
---|---|---|---|---|
48 | K | ubiquitylation |
| 30258100 |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of SPDLY_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
GPS2_HUMAN | GPS2 | physical | 16169070 | |
CE126_HUMAN | KIAA1377 | physical | 16169070 | |
YLPM1_HUMAN | YLPM1 | physical | 22939629 | |
NEK9_HUMAN | NEK9 | physical | 22863883 | |
SPDLY_HUMAN | SPDL1 | physical | 25416956 | |
DAAF4_HUMAN | DYX1C1 | physical | 25416956 | |
PPR18_HUMAN | PPP1R18 | physical | 25416956 | |
RTP5_HUMAN | RTP5 | physical | 25416956 | |
SYHC_HUMAN | HARS | physical | 26344197 | |
PSDE_HUMAN | PSMD14 | physical | 26344197 | |
RS5_HUMAN | RPS5 | physical | 26344197 | |
UBXN1_HUMAN | UBXN1 | physical | 26344197 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry."; Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.; Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-555, AND MASSSPECTROMETRY. | |
"Improved titanium dioxide enrichment of phosphopeptides from HeLacells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra."; Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.; J. Proteome Res. 6:4150-4162(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-515, AND MASSSPECTROMETRY. | |
"ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage."; Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.; Science 316:1160-1166(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-487, AND MASSSPECTROMETRY. |